Fieldpoint Private Securities’s BioTelemetry, Inc. BEAT Stock Holding History

Fieldpoint Private Securities’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-45	Closed	-$3K	–	1676
2020 Q4	$3K	Buy	+45	New	+$2.36K	﹤0.01%	1285

Other funds holding BEAT

LCM

Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return

Fieldpoint Private Securities's BEAT Position: Q1 2021 in Review

Fieldpoint Private Securities sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 45 shares — an estimated $3K sold.

Fieldpoint Private Securities first reported a position in BEAT in Q4 2020 and held it in 1 quarter. The position peaked at $3K in Q4 2020. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

Fieldpoint Private Securities reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
Fieldpoint Private Securities sold 45 BioTelemetry, Inc. shares in Q1 2021, an estimated $3K.
Fieldpoint Private Securities first reported a position in BioTelemetry, Inc. in Q4 2020 and held it in 1 quarter.
Fieldpoint Private Securities's BioTelemetry, Inc. position peaked at $3K in Q4 2020.
1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on Fieldpoint Private Securities's 13F filing for Q1 2021, filed 23 Apr 2021.